Back to results
US 11,447,546 B2Granted
Human antibodies binding to ROR2
AssigneeNbe-Therapeutics AG
InventorsUlf Grawunder, Roger Beerli, Ina Hellmann, Lorenz Waldmeier
Life of this patent
Estimating the term…
Abstract
The present invention relates to fully human antibodies and conjugates thereof, which specifically bind to the extracellular domain of receptor tyrosine kinase-like orphan receptor 2 (ROR2).
Claims5
A fully human antibody, or antigen-binding fragment thereof, which specifically binds to the extracellular domain of receptor tyrosine kinase-like orphan receptor 2 (ROR2)
- which comprises one of the following CDR sets:
- a) heavy chain CDRs 1-3 as set forth in SEQ ID NOs 38, 39 and 40, respectively, and light chain CDRs 1 and 3 as set forth in SEQ ID NOs 29 and 41, respectively, with light chain CDR 2 having the sequence KAS;
- b) heavy chain CDRs 1-3 as set forth in SEQ ID NOs 26-28, respectively, and light chain CDRs 1-3 as set forth in SEQ ID NOs 29, 73 and 30, respectively;
- c) heavy chain CDRs 1-3 as set forth in SEQ ID NOs 94, 32 and 44, respectively, and light chain CDRs 1 and 3 as set forth in SEQ ID NOs 29 and 42, respectively, with light chain CDR 2 having the sequence KAS;
- d) heavy chain CDRs 1-3 as set forth in SEQ ID NOs 38, 46 and 52, respectively, and light chain CDRs 1 and 3 as set forth in SEQ ID NOs 50 and 53, respectively, with light chain CDR 2 having the sequence AAS;
- e) heavy chain CDRs 1-3 as set forth in SEQ ID NOs 38, 54 and 55, respectively, and light chain CDRs 1 and 3 as set forth in SEQ ID NOs 56 and 57, respectively, with light chain CDR 2 having the sequence LGS;
- f) heavy chain CDRs 1-3 as set forth in SEQ ID NOs 58-60, respectively, and light chain CDRs 1 and 3 as set forth in SEQ ID NOs 61, and 62, respectively, with light chain CDR 2 having the sequence KAS,
- g) heavy chain CDRs 1-3 as set forth in SEQ ID NOs 63-65, respectively, with light chain CDRs 1 and 3 as set forth in SEQ ID NOs 50 and 66, respectively, with light chain CDR 2 having the sequence AAS.
5 more elements
A fully human antibody, or antigen-binding fragment thereof, which specifically binds to the extracellular domain of receptor tyrosine kinase-like orphan receptor 2 (ROR2), wherein said antibody comprises
- an Ig heavy chain variable region sequence and an Ig light chain variable region sequence, respectively, shown in:
- (i) SEQ ID NO:2 and SEQ ID NO:3;
- (ii) SEQ ID NO:4 and SEQ ID NO:5;
- (iii) SEQ ID NO:6 and SEQ ID NO:7;
- (iv) SEQ ID NO:8 and SEQ ID NO:9;
- (v) SEQ ID NO:10 and SEQ ID NO:11;
- (vi) SEQ ID NO:12 and SEQ ID NO:13;
- (vii) SEQ ID NO:14 and SEQ ID NO:15;
- (vii) SEQ ID NO:16 and SEQ ID NO:17;
- (ix) SEQ ID NO:18 and SEQ ID NO:19;
- (x) SEQ ID NO:20 and SEQ ID NO:21;
- (xi) SEQ ID NO:22 and SEQ ID NO:23;
- or
- (xii) SEQ ID NO:24 and SEQ ID NO:25.
11 more elements
Dependencies are inferred from the claim text.